X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1822) 1822
Publication (145) 145
Newsletter (58) 58
Book Chapter (19) 19
Book Review (18) 18
Newspaper Article (13) 13
Book / eBook (3) 3
Magazine Article (3) 3
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1536) 1536
mycosis-fungoides (807) 807
male (757) 757
dermatology (704) 704
female (704) 704
index medicus (690) 690
mycosis fungoides (690) 690
middle aged (632) 632
skin neoplasms - pathology (549) 549
aged (540) 540
adult (522) 522
sezary-syndrome (515) 515
skin neoplasms - genetics (433) 433
t-cell lymphoma (414) 414
mycosis fungoides - pathology (403) 403
mycosis fungoides - genetics (347) 347
t cells (333) 333
aged, 80 and over (289) 289
lymphoma, t-cell, cutaneous - pathology (281) 281
oncology (275) 275
mycoses (273) 273
skin (273) 273
lymphomas (267) 267
pathology (258) 258
cutaneous t-cell lymphoma (251) 251
lymphoma (246) 246
non-hodgkin's lymphomas (246) 246
expression (243) 243
cancer (233) 233
polymerase chain reaction (226) 226
immunohistochemistry (225) 225
hematology (221) 221
lymphoma, t-cell, cutaneous - genetics (220) 220
diagnosis (216) 216
skin neoplasms - diagnosis (209) 209
prognosis (199) 199
skin neoplasms - immunology (195) 195
skin - pathology (190) 190
cell biology (185) 185
sezary syndrome (181) 181
biopsy (172) 172
classification (169) 169
mycosis fungoides - diagnosis (164) 164
lymphocytes (163) 163
diagnosis, differential (161) 161
sezary syndrome - genetics (156) 156
molecular biology (155) 155
adolescent (153) 153
mycosis fungoides - immunology (146) 146
sezary syndrome - pathology (146) 146
dermatology & venereal diseases (140) 140
skin neoplasms - metabolism (139) 139
biochemistry (136) 136
analysis (133) 133
research (133) 133
sézary syndrome (131) 131
neoplasm staging (123) 123
retrospective studies (118) 118
disease (117) 117
leukemia (117) 117
skin neoplasms - therapy (116) 116
skin neoplasms - drug therapy (113) 113
immunophenotyping (111) 111
genetic aspects (108) 108
lymphoma, t-cell, cutaneous - immunology (108) 108
child (104) 104
animals (101) 101
care and treatment (101) 101
gene expression regulation, neoplastic (101) 101
mycosis fungoides - metabolism (101) 101
peripheral-blood (101) 101
gene rearrangement (100) 100
polymerase-chain-reaction (100) 100
disease progression (99) 99
lymphoma, t-cell, cutaneous - metabolism (97) 97
lymphoma, t-cell, cutaneous - diagnosis (95) 95
tumors (94) 94
fungal infections (90) 90
t-lymphocytes - pathology (89) 89
apoptosis (88) 88
cell line, tumor (86) 86
lymphocytes t (84) 84
treatment outcome (84) 84
t-lymphocytes - immunology (82) 82
clone cells (81) 81
mycosis (81) 81
mycosis fungoides - therapy (81) 81
prognostic-factors (81) 81
sezary syndrome - immunology (80) 80
lymphoproliferative disorders (79) 79
flow cytometry (78) 78
base sequence (76) 76
development and progression (76) 76
hemic and lymphatic diseases (76) 76
lymphoma, t-cell, cutaneous - drug therapy (76) 76
young adult (76) 76
gene expression (74) 74
cutaneous lymphoma (73) 73
receptors, antigen, t-cell - genetics (73) 73
article (70) 70
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1872) 1872
German (12) 12
French (10) 10
Japanese (5) 5
Russian (5) 5
Spanish (5) 5
Chinese (4) 4
Portuguese (3) 3
Polish (2) 2
Hungarian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 08/2015, Volume 47, Issue 9, pp. 1056 - 1060
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 23, pp. 2698 - 2704
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2011, Volume 155, Issue 2, pp. 150 - 166
Summary Cutaneous T‐cell lymphomas (CTCL) are a heterogeneous group of malignancies derived from skin‐homing T cells. The most common forms of CTCL are Mycosis... 
cutaneous T‐cell lymphoma | cytokines | Sezary syndrome | interleukin 15 | mycosis fungoides | Mycosis fungoides | Cytokines | Interleukin 15 | Cutaneous T-cell lymphoma | PEGYLATED LIPOSOMAL DOXORUBICIN | DENILEUKIN DIFTITOX | HISTONE DEACETYLASE INHIBITOR | INTERNATIONAL-SOCIETY | SUBEROYLANILIDE HYDROXAMIC ACID | cutaneous T-cell lymphoma | PHASE-II | MONOCLONAL-ANTIBODY | DOSE INTERFERON-ALPHA | GENE-EXPRESSION | CHRONIC LYMPHOCYTIC-LEUKEMIA | HEMATOLOGY | Immunologic Surveillance | Mycosis Fungoides - immunology | Immunotherapy - methods | Clinical Trials as Topic - statistics & numerical data | Genes, Neoplasm | Humans | Antibodies, Monoclonal - therapeutic use | Sezary Syndrome - epidemiology | Mycosis Fungoides - epidemiology | Mycosis Fungoides - therapy | Cell Differentiation | Antigens, Neoplasm - analysis | Mycosis Fungoides - genetics | Sezary Syndrome - immunology | Multicenter Studies as Topic - statistics & numerical data | Cytokines - metabolism | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Biomarkers, Tumor - analysis | Hematopoietic Stem Cell Transplantation | Mycosis Fungoides - etiology | Skin Neoplasms - epidemiology | Disease Progression | Sezary Syndrome - etiology | Animals | T-Lymphocyte Subsets - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Transformation, Neoplastic | Sezary Syndrome - therapy | T-Lymphocyte Subsets - metabolism | Skin Neoplasms - genetics | Chromosome Aberrations | Histone Deacetylase Inhibitors - therapeutic use | Mice | Skin Neoplasms - etiology | Sezary Syndrome - genetics | Immunologic Factors - therapeutic use | Antimitotic agents | Care and treatment | Genetic research | Mycoses | Genetics | Non-Hodgkin's lymphomas | Gene expression | T cells | Antineoplastic agents | Cancer | Histone deacetylase | Genetic markers | biomarkers | Immunopathogenesis | Lymphocytes T | Malignancy | Skin | Epidemiology | T-cell lymphoma
Journal Article
Journal Article